Close Menu

NEW YORK (GenomeWeb) – Veracyte said today that it has closed its previously announced public offering of common stock, raising $55.1 million in net proceeds from the sale of nearly 5.8 million shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.